[Danazol - effective second line therapy in idiopathic thrombocytopenic purpura in children. Three case reports].
Danazol is an accredited second line drug for idiopathic thrombocytopenic purpura (ITP) in adults. There are very few positions in the literature about using danazol in children, although some articles quote its evident efficacy. In this paper we present three cases of children treated with danazol. The routine treatment in these ITP cases was ineffective. The result was stabilization of platelet count and avoidance of splenectomy.
Szmydki-Baran
Anna
A
Katedra i Klinika Pediatrii, Hematologii i Onkologii WUM w Warszawie, ul. Marszałkowska 24, 00-576 Warszawa, Poland. aszmydki@tlen.pl.
Adamowicz-Salach
Anna
A
Gołebiowska-Staroszczyk
Sydonia
S
D002648:Child; D003613:Danazol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D013156:Splenectomy; D017211:Treatment Failure
D003613:Danazol